EUVIMEDEUVIMED entdecken
Crossref

NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain

Huanzhi Han, Bowen Li, Run Yang, Hao-Lin Guo, Qiuya Li, Hua Wang, Bin Zheng iD, Yang Bai, Yonghao Yu

ACS Biomaterials Science & Engineering · 12.08.2024 · 10 (8) · 5001-5013

DOI: 10.1021/acsbiomaterials.4c00733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 16.07.2024. Verfasst von Huanzhi Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin 300052, China. Hauptthemen laut MEDLINE: Neuralgia, Needles, Infrared Rays, Buprenorphine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin Municipality, National Natural Science Foundation of China, Tianjin Key Medical Discipline (Specialty) Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain is a prevalent form of intermittent chronic pain, affecting approximately 7-10% of the global population. However, the current clinical administration methods, such as injection and oral administration, are mostly one-time administration, which cannot achieve accurate control of pain degree and drug dose. Herein, we developed near-infrared (NIR) light-responsive microneedle patches (MNPs) to spatiotemporally control the drug dose released to treat neuropathic pain according to the onset state. The mechanism of action utilizes upconversion nanoparticles to convert NIR light into visible and ultraviolet light. This conversion triggers the rapid rotation of the azobenzene molecular motor in the mesoporous material, enabling the on-demand controlled release of a drug dose. Additionally, MNs are used to overcome the barrier of the stratum corneum in a minimally invasive and painless manner, effectively promoting the transdermal penetration of drug molecules. The effectiveness of these patches has been demonstrated through significant results. Upon exposure to NIR light for five consecutive cycles, with each cycle lasting 30 s, the patches achieved a precise release of 318 μg of medication. In a mouse model, maximum pain relief was observed within 1 h of one cycle of NIR light exposure, with the effects lasting up to 6 h. The same level of precise treatment efficacy was maintained for subsequent pain episodes with similar light exposure. The NIR-controlled drugs precision-released MNPs provide a novel paradigm for the treatment of intermittent neuropathic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaNeedlesInfrared RaysBuprenorphineAnimalsMiceMaleTransdermal PatchAdministration, CutaneousDrug LiberationDrug Delivery SystemsNanoparticles

Stichwörter der Autor:innen

NIR-remote selectively triggeredcontrolled drug releasemicroneedle patchmolecular motorneuropathic pain

Substanzen

Buprenorphine

Autor:innen und Institutionen

  • Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Qilu Hospital of Shandong University Dezhou Hospital, Dezhou 253000, China.
  • Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin 300072, China.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102401, China.
  • School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin 300070, China.
  • Tianjin Research Institute of Anesthesiology, Tianjin 300052, China.

ORCID-Profile: Bin Zheng

Förderung

  • Natural Science Foundation of Tianjin Municipality
  • National Natural Science Foundation of China
  • Tianjin Key Medical Discipline (Specialty) Construction Project

Zitieren

APA

Han, H., Li, B., Yang, R., Guo, H. L., Li, Q., Wang, H., Zheng, B., Bai, Y., & Yu, Y. (2024). NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain. ACS Biomaterials Science & Engineering, 10(8), 5001-5013. https://doi.org/10.1021/acsbiomaterials.4c00733

Vancouver

Han H, Li B, Yang R, Guo HL, Li Q, Wang H, et al. NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain. ACS Biomaterials Science & Engineering. 2024;10(8):5001-5013. doi:10.1021/acsbiomaterials.4c00733

BibTeX
@article{Han2024,
  author = {Han, Huanzhi and Li, Bowen and Yang, Run and Guo, Hao-Lin and Li, Qiuya and Wang, Hua and Zheng, Bin and Bai, Yang and Yu, Yonghao},
  title = {NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2024},
  volume = {10},
  number = {8},
  pages = {5001--5013},
  doi = {10.1021/acsbiomaterials.4c00733}
}
Kostenlos starten →